$101.11
▼ -0.4% Today
as of Aug 5, 16:51 ET
Last 30 days
Recent Press Releases & News
LNTH: Lowering target price to $106.00
Lantheus (LNTH) Agrees To Join Curium In Radiopharmaceuticals Deal
MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading
Overview
52-week range
$47
$104
95% of range
Avg surprise (last 3)
-0.2%
Avg reaction (last 2)
-8.8%
50% positive
Latest IV / EM
24%
EM ±4.1% · $100 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $1.21 | $1.02 | +18.6% | -6.9% | +5.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.41 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $1.32 | $1.43 | -7.7% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $1.30 | $1.47 | -11.6% | — | -23.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.79 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.88 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $1.87 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.88 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.33 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | BMO | $1.11 | $1.32 | -15.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $231M | — | $222M | $241M | $238M | — | $242M | $256M |
| Operating income | $81M | — | $44M | $88M | $102M | — | $134M | $103M |
| Net income | $118M | — | $28M | $79M | $73M | — | $131M | $62M |
| EPS (diluted) | $1.80 | — | $0.41 | $1.12 | $1.02 | — | $1.79 | $0.88 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $499M | $359M | $382M | $696M | $939M | $913M | $866M | $757M |
| Inventory | $61M | $65M | $62M | $62M | $69M | $68M | $71M | $71M |
| Total current assets | $942M | $900M | $925M | $1.20B | $1.42B | $1.33B | $1.30B | $1.23B |
| Total assets | $2.35B | $2.23B | $2.28B | $2.12B | $2.06B | $1.98B | $2.05B | $1.94B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.13B | $1.14B | $1.16B | $949M | $891M | $892M | $870M | $913M |
| Total equity | $1.21B | $1.09B | $1.12B | $1.17B | $1.16B | $1.09B | $1.18B | $1.03B |